Revolution Medicines, Inc. <RVMD.O>: Oppenheimer raises target price to $260 from $230
RVMD•Related News
U.S. Gold to Present at Moody Capital Solutions Disruptive Growth & Life Sciences Conference
USAU•
Green Brick Partners director Harry Brandler resigns from board
GRBK•
StepStone Group Inc. <STEP.O>: Oppenheimer cuts target price to $88 from $90
STEP•
Farmmi posts six-month net loss as March 31, 2026 credit-loss provisions surge on supplier advances write-down
FAMI•
Lucky Strike Entertainment slips after Q4 revenue miss
LUCK•